Newly Diagnosed Multiple Myeloma Terminated Phase 3 Trials for Prednisone (DB00635)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00644306Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple MyelomaTreatment